Satori Capital, a multi-strategy investment firm founded on the principles of conscious capitalism, announced the launch of a new business focused on transformational companies developing innovative solutions for mental health.
Dr. Amy Kruse has more than 20 years of experience in science, technology, and innovation, with a special focus on neurotechnology and human performance. She has been named the head of Satori Neuro. She is a former general partner at Prime Movers Lab, a venture capital firm that invests in early-stage scientific-driven startups developing solutions to some of the world’s most pressing problems. Previously, she served as Chief Scientific Officer of applied neuroscience research company Optios, and she has prior experience as Chief Technology Officer of Cubic Global Defense and as a Program Manager at the Defense Advanced Research Projects Agency (DARPA). Kruse has both a Bachelor of Science in cell and structural biology and a Ph.D. in neuroscience from the University of Illinois Urbana-Champaign.